GENERAL
Sun Pharma Gets South Africa Nod For Generic Semaglutide Injection
Sun Pharmaceutical Industries Ltd (Sun Pharma) has received approval from the South African Health Products Regulatory Authority (SAHPRA) to manufacture and market a generic version of Semaglutide injection for the treatment of adults with inadequately controlled Type 2 diabetes mellitus. The approval marks South Africa as the second market after India where Sun Pharma has […]
CW Bureau
·
Jul 15, 2026
GENERAL
Biocon Partner Bags Malaysia Insulin Contracts Worth Over MYR 225 Mn
Biocon Ltd, an innovation-led global biopharmaceutical company, said its long-standing partner, Duopharma Biotech Berhad, through its wholly owned subsidiary Duopharma (M) Sendirian Berhad, has secured multiple insulin supply contracts from Malaysia’s Ministry of Health (MoH) worth more than MYR 225 million. Under the contracts, Biocon’s Malaysian subsidiary, Biocon Sdn. Bhd., will supply short-acting recombinant human […]
CW Bureau
·
Jun 24, 2026
GENERAL
Aurobindo Pharma Gets USFDA Nod For Dapagliflozin-Metformin Combo
Aurobindo Pharma Ltd has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Dapagliflozin and Metformin Hydrochloride extended-release tablets in multiple strengths such as 5 mg/500 mg, 5 mg/1000 mg, 10 mg/500 mg, and 10 mg/1000 mg. The approved formulation is bioequivalent and therapeutically equivalent to the reference listed […]
CW Bureau
·
Apr 7, 2026
